Boston Trust Walden Corp Haemonetics Corp Transaction History

Boston Trust Walden Corp

$14.1 Billion
Q3 2024

A detailed history of Boston Trust Walden Corp transactions in Haemonetics Corp stock. As of the latest transaction made, Boston Trust Walden Corp holds 809,608 shares of HAE stock, worth $59.2 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

809,608

Previous 711,589 13.77%

Holding current value

$59.2 Million

Previous $58.9 Million 10.53%

% of portfolio

0.46%

Previous 0.44%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$72.45 - $91.58 $7.1 Million - $8.98 Million	98,019 Added 13.77%	809,608 $65.1 Million
Q2 2024 Jul 19, 2024	SELL	$81.24 - $97.37 $22,422 - $26,874	-276 Reduced 0.04%	711,589 $58.9 Million
Q1 2024 Apr 22, 2024	SELL	$71.24 - $85.35 $327,775 - $392,695	-4,601 Reduced 0.64%	711,865 $60.8 Million
Q4 2023 Jan 24, 2024	SELL	$80.59 - $92.61 $327,437 - $376,274	-4,063 Reduced 0.56%	716,466 $61.3 Million
Q3 2023 Oct 18, 2023	BUY	$82.56 - $93.49 $4.27 Million - $4.83 Million	51,669 Added 7.72%	720,529 $64.5 Million
Q2 2023 Jul 24, 2023	BUY	$80.84 - $89.45 $1.61 Million - $1.78 Million	19,953 Added 3.07%	668,860 $56.9 Million
Q1 2023 Apr 19, 2023	BUY	$72.75 - $90.6 $1.72 Million - $2.14 Million	23,651 Added 3.78%	648,907 $53.7 Million
Q4 2022 Jan 20, 2023	SELL	$73.85 - $86.14 $263,570 - $307,433	-3,569 Reduced 0.57%	625,256 $0
Q3 2022 Oct 19, 2022	BUY	$63.3 - $78.66 $1.32 Million - $1.64 Million	20,849 Added 3.43%	628,825 $46.6 Million
Q2 2022 Jul 22, 2022	SELL	$49.27 - $66.08 $11 Million - $14.7 Million	-222,914 Reduced 26.83%	607,976 $39.6 Million
Q1 2022 Apr 20, 2022	BUY	$43.77 - $63.22 $8.29 Million - $12 Million	189,457 Added 29.54%	830,890 $52.5 Million
Q4 2021 Jan 21, 2022	BUY	$49.55 - $74.59 $9 Million - $13.5 Million	181,560 Added 39.48%	641,433 $34 Million
Q3 2021 Oct 25, 2021	BUY	$57.6 - $70.59 $13.8 Million - $17 Million	240,419 Added 109.55%	459,873 $32.5 Million
Q2 2021 Jul 22, 2021	SELL	$51.81 - $118.56 $497,427 - $1.14 Million	-9,601 Reduced 4.19%	219,454 $14.6 Million
Q1 2021 Apr 21, 2021	SELL	$111.01 - $139.48 $2.9 Million - $3.64 Million	-26,117 Reduced 10.24%	229,055 $25.4 Million
Q4 2020 Jan 15, 2021	BUY	$88.75 - $119.95 $36,210 - $48,939	408 Added 0.16%	255,172 $30.3 Million
Q3 2020 Oct 14, 2020	BUY	$75.65 - $93.58 $4.14 Million - $5.12 Million	54,748 Added 27.37%	254,764 $22.2 Million
Q2 2020 Jul 23, 2020	BUY	$84.96 - $118.91 $2.13 Million - $2.97 Million	25,014 Added 14.29%	200,016 $17.9 Million
Q1 2020 Apr 24, 2020	SELL	$74.34 - $121.82 $2.51 Million - $4.11 Million	-33,740 Reduced 16.16%	175,002 $17.4 Million
Q1 2020 Apr 21, 2020	BUY	$74.34 - $121.82 $6.49 Million - $10.6 Million	87,257 Added 71.83%	208,742 $20.8 Million
Q4 2019 Jan 10, 2020	BUY	$114.37 - $129.46 $291,186 - $329,605	2,546 Added 2.14%	121,485 $14 Million
Q3 2019 Oct 21, 2019	BUY	$117.16 - $138.52 $107,787 - $127,438	920 Added 0.78%	118,939 $15 Million
Q2 2019 Jul 25, 2019	SELL	$81.74 - $120.34 $128,577 - $189,294	-1,573 Reduced 1.32%	118,019 $14.2 Million
Q1 2019 Apr 16, 2019	SELL	$83.25 - $102.12 $2.73 Million - $3.35 Million	-32,814 Reduced 21.53%	119,592 $10.5 Million
Q4 2018 Jan 17, 2019	SELL	$90.66 - $116.63 $6.16 Million - $7.93 Million	-67,955 Reduced 30.84%	152,406 $15.2 Million
Q3 2018 Oct 23, 2018	SELL	$89.96 - $114.58 $1.11 Million - $1.42 Million	-12,383 Reduced 5.32%	220,361 $25.2 Million
Q2 2018 Jul 25, 2018	SELL	$71.53 - $95.75 $2.41 Million - $3.22 Million	-33,680 Reduced 12.64%	232,744 $20.9 Million
Q1 2018 Apr 13, 2018	SELL	$60.72 - $74.41 $1.25 Million - $1.53 Million	-20,612 Reduced 7.18%	266,424 $19.5 Million
Q4 2017 Jan 29, 2018	SELL	$44.96 - $58.99 $348,664 - $457,467	-7,755 Reduced 2.63%	287,036 $16.7 Million
Q3 2017 Oct 13, 2017	BUY	$40.38 - $44.87 $11.9 Million - $13.2 Million	294,791	294,791 $13.2 Million

Others Institutions Holding HAE

# of Institutions

336

Shares Held

55.7M

Call Options Held

383K

Put Options Held

45.1K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.75B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Trust Walden Corp, based on Form 13F filings with the SEC.

News

Stay updated on Boston Trust Walden Corp with notifications on news.

Account

Boston Trust Walden Corp Haemonetics Corp Transaction History